Plus, news about Syncona, Ventus Therapeutics, Roche, Disc Medicine, Atai Life Sciences, Lexeo Therapeutics, Novartis, Vivace Therapeutics, Kura Oncology, Corbus and J&J:
💼 Neuphoria Therapeutics’ social anxiety drug fails Phase 3: The biotech is discontinuing ...
↧